Meet Me in the Middle: Lessons From the Cardiorenal Advisory Committee for Sacubitril/Valsartan in HFpEF

JACC Heart Fail. 2021 Feb;9(2):161-163. doi: 10.1016/j.jchf.2020.12.003.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Advisory Committees
  • Aminobutyrates / therapeutic use
  • Angiotensin Receptor Antagonists / adverse effects
  • Biphenyl Compounds
  • Drug Combinations
  • Heart Failure* / drug therapy
  • Humans
  • Stroke Volume
  • Tetrazoles / adverse effects
  • Valsartan

Substances

  • Aminobutyrates
  • Angiotensin Receptor Antagonists
  • Biphenyl Compounds
  • Drug Combinations
  • Tetrazoles
  • Valsartan
  • sacubitril and valsartan sodium hydrate drug combination